Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells

(2011) M Comamala et al.   BRITISH JOURNAL OF CANCER

MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis

(2011) Catherine Thériault et al.   GYNECOLOGIC ONCOLOGY

Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer

(2011) Junji Ieda et al.   INTERNATIONAL JOURNAL OF CANCER

Netrin-1 Mediates Early Events in Pancreatic Adenocarcinoma Progression, Acting on Tumor and Endothelial Cells

(2010) Laurent Dumartin et al.   GASTROENTEROLOGY

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

(2009) W-F Cheng et al.   BRITISH JOURNAL OF CANCER

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling

(2009) Seiko Hirono et al.   CANCER SCIENCE

HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA

(2009) P Fritsche et al.   GUT

Consensus transcriptome signature of perineural invasion in pancreatic carcinoma

(2009) I. Abiatari et al.   MOLECULAR CANCER THERAPEUTICS

Prognostic Role of Osteopontin Expression in Malignant Pleural Mesothelioma

(2008) Susanna Cappia et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer

(2008) E J Campbell et al.   BRITISH JOURNAL OF CANCER

Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes

(2008) R. R. Seethala et al.   CLINICAL CANCER RESEARCH